Skip to Main content Skip to Navigation
Journal articles

Authors’ Reply to the Letter by Shoar et al. on “Glycosylated Hemoglobin as a Surrogate for the Prevention of Cardiovascular Events in Cardiovascular Outcome Trials Comparing New Antidiabetic Drugs to Placebo”

Pierre Ambrosi 1, 2 Aurélie Daumas 1 Patrick Villani 1 Roch Giorgi 3, 4
1 Médecine Interne Thérapeutique Post-Urgence - Gériatrie [Hôpital de la Timone - APHM]
2 Département de Cardiologie [Hôpital de la Timone - APHM]
3 SESSTIM - U1252 INSERM - Aix Marseille Univ - UMR 259 IRD - Sciences Economiques et Sociales de la Santé & Traitement de l'Information Médicale
4 BiosTIC - Biostatistique et technologies de l'information et de la communication (BioSTIC) - [Hôpital de la Timone - APHM]
Abstract : No abstract available
Document type :
Journal articles
Complete list of metadatas
https://www.hal.inserm.fr/inserm-03090462
Contributor : Christine Dupuis <>
Submitted on : Tuesday, December 29, 2020 - 4:48:58 PM
Last modification on : Wednesday, December 30, 2020 - 3:32:06 AM

File

 Restricted access
To satisfy the distribution rights of the publisher, the document is embargoed until : jamais

Please log in to resquest access to the document

Identifiers

Collections

INSERM | UNIV-AMU | U1252 | IRD

Citation

Pierre Ambrosi, Aurélie Daumas, Patrick Villani, Roch Giorgi. Authors’ Reply to the Letter by Shoar et al. on “Glycosylated Hemoglobin as a Surrogate for the Prevention of Cardiovascular Events in Cardiovascular Outcome Trials Comparing New Antidiabetic Drugs to Placebo”. Cardiology, Karger, 2020, 145 (6), pp.387-387. ⟨10.1159/000507361⟩. ⟨inserm-03090462⟩

Export

BibTeX TEI DC DCterms EndNote

Share

Metrics

Record views

115